Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials. While stem cell therapies can be effective, they are also associated with some risks of both tumor growth and immune rejection. Also, the cells themselves are very fragile, requiring careful storage and a multi-step process of typing and characterization before they can be used.
Ke Cheng, associate professor of molecular biomedical sciences at NC State, associate professor in the joint biomedical engineering program at NC State and UNC, and adjunct associate professor at the UNC Eshelman School of Pharmacy, led a team in developing the synthetic version of a cardiac stem cell that could be used in off-the-shelf applications.
Cheng and his colleagues fabricated a cell-mimicking microparticle (CMMP) from poly (lactic-co-glycolic acid) or PLGA, a biodegradable and biocompatible polymer. The researchers then harvested growth factor proteins from cultured human cardiac stem cells and added them to the PLGA. Finally, they coated the particle with cardiac stem cell membrane.
“We took the cargo and the shell of the stem cell and packaged it into a biodegradable particle,” Cheng says.
When tested in vitro, both the CMMP and cardiac stem cell promoted the growth of cardiac muscle cells. They also tested the CMMP in a mouse model with myocardial infarction, and found that its ability to bind to cardiac tissue and promote growth after a heart attack was comparable to that of cardiac stem cells. Due to its structure, CMMP cannot replicate – reducing the risk of tumor formation.
“The synthetic cells operate much the same way a deactivated vaccine works,” Cheng says. “Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.”
The synthetic stem cells are much more durable than human stem cells, and can tolerate harsh freezing and thawing. They also don’t have to be derived from the patient’s own cells. And the manufacturing process can be used with any type of stem cell.
“We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they’re needed, without costly delays,” Cheng says.
Learn more: Synthetic Stem Cells Could Offer Therapeutic Benefits, Reduced Risks
[osd_subscribe categories=’stem-cells’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “STEM CELLS”‘]
Receive an email update when we add a new STEM CELLS article.
The Latest on: Stem cells
[google_news title=”” keyword=”stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cells
- Stem Cell Injections in Mexico Led to Drug-Resistant Infectionson May 9, 2024 at 1:34 pm
Three patients developed difficult-to-treat Mycobacterium abscessus infections after receiving embryonic stem cell injections in Mexico in 2022, researchers reported. Two men -- o ...
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infectionson May 9, 2024 at 12:35 pm
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- Researchers identify highly drug-resistant infections from stem cell treatments in Mexicoon May 9, 2024 at 11:30 am
Experts in mycobacterial diseases at National Jewish Health, in collaboration with local health departments and the Centers for Disease Control and Prevention (CDC), are investigating a potential ...
- 12-year-old spreads awareness on stem donation after receiving gift of lifeon May 9, 2024 at 10:32 am
BOTTOM OF YOUR SCREEN. WELL, LOCAL FAMILY IS CELEBRATING A MEDICAL BREAKTHROUGH AFTER UNDERGOING A SUCCESSFUL PEDIATRIC STEM CELL TRANSPLANT. THIS WAS MADE POSSIBLE THROUGH STEM DONATIONS, BUT ...
- Stem cell injections in Mexico can be hazardous. Report identifies US victims.on May 9, 2024 at 10:19 am
Two cases of bacterial infection shared identical genetic material even thought the procedures took place hundreds of miles apart.
- Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexicoon May 9, 2024 at 10:00 am
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- New stem cell research may have implications for liver transplantationon May 9, 2024 at 9:20 am
One important question is whether liver cells grown in a different species would be fully functional. To find out, Wei Li and colleagues from the Chinese Academy of Sciences in Beijing injected mouse ...
- Stem Cell Transplants Show Improved Survival Rates Across Ethnic Groupson May 9, 2024 at 6:30 am
Researchers have revealed significant advancements in haematopoietic cell transplants across diverse racial and ethnic populations.
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight riskson May 9, 2024 at 2:00 am
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
via Bing News